Aerovate Therapeutics Inc
AVTE2.680USD
0.000
Close 08/04, 16:00（ET）Quotes delayed by 15 min
0.000USD0.000After-hours 08/04, 20:00 (ET)
77.68MMarket Cap
LossP/E TTM
Aerovate Therapeutics Inc
2.680
0.000
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
25.36%-11.05M
-2.77%-16.04M
-36.74%-20.43M
-107.22%-23.67M
0.44%-14.80M
-60.61%-15.61M
-68.35%-14.94M
-101.80%-11.42M
---14.87M
---9.72M
---8.88M
---5.66M
Net income from continuing operations
73.40%-5.43M
17.00%-16.24M
-30.22%-24.77M
-40.35%-23.19M
-35.89%-20.41M
-43.97%-19.56M
-58.66%-19.02M
-51.42%-16.52M
---15.02M
---13.59M
---11.99M
---10.91M
Operating gains losses
-71.43%8.00K
772.00%218.00K
27.27%28.00K
33.33%28.00K
40.00%28.00K
25.00%25.00K
29.41%22.00K
90.91%21.00K
--20.00K
--20.00K
--17.00K
--11.00K
Other non-cash items
91.48%-80.00K
42.95%-461.00K
-8.29%-692.00K
-13.11%-759.00K
-60.24%-939.00K
-176.71%-808.00K
-947.54%-639.00K
-2413.79%-671.00K
---586.00K
---292.00K
---61.00K
--29.00K
Change in working capital
-307.39%-6.79M
-204.54%-1.57M
-31.47%1.14M
-217.67%-3.96M
425.35%3.27M
-43.28%1.50M
-13.95%1.67M
-19.67%3.36M
---1.01M
--2.64M
--1.94M
--4.18M
-Change in prepaid expenses
-37.64%381.00K
15710.00%4.68M
-261.44%-2.65M
-432.08%-2.11M
102.32%611.00K
97.32%-30.00K
-121.82%-734.00K
-70.13%636.00K
--302.00K
---1.12M
--3.36M
--2.13M
-Change in other current assets
-465.00%-226.00K
-11373.33%-1.72M
7276.47%2.51M
102.25%2.00K
97.27%-40.00K
-171.43%-15.00K
108.44%34.00K
-256.00%-89.00K
---1.47M
--21.00K
---403.00K
---25.00K
-Change in other current liabilities
37.41%-169.00K
97.30%219.00K
-19.23%-279.00K
4255.56%392.00K
-103.01%-270.00K
--111.00K
---234.00K
--9.00K
---133.00K
----
----
----
Cash from non-recurring investing activities
Cash from operating activities
25.36%-11.05M
-2.77%-16.04M
-36.74%-20.43M
-107.22%-23.67M
0.44%-14.80M
-60.61%-15.61M
-68.35%-14.94M
-101.80%-11.42M
---14.87M
---9.72M
---8.88M
---5.66M
Investing cash flow
Net cash from continuing investing activities
----
----
----
-100.00%0.00
1500.00%64.00K
-3.03%32.00K
-76.92%30.00K
-42.86%16.00K
--4.00K
--33.00K
--130.00K
--28.00K
Capital expenditures
----
----
----
-100.00%0.00
1500.00%64.00K
-3.03%32.00K
-76.92%30.00K
-42.86%16.00K
--4.00K
--33.00K
--130.00K
--28.00K
Net cash flow from disposal of fixed assets
----
----
----
-100.00%0.00
1500.00%64.00K
-3.03%32.00K
-76.92%30.00K
-42.86%16.00K
--4.00K
--33.00K
--130.00K
--28.00K
Net cash flow from investment products
129.85%13.13M
222.67%16.07M
348.54%18.00M
-42.61%8.83M
-60.58%5.71M
-379.99%-13.10M
-51.79%4.01M
175.55%15.39M
--14.49M
--4.68M
--8.32M
---20.37M
Net cash flow from other investing activities
--0.00
----
----
----
----
----
----
----
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
132.45%13.13M
222.37%16.07M
351.92%18.00M
-42.55%8.83M
-61.01%5.65M
-382.67%-13.13M
-51.39%3.98M
175.37%15.38M
--14.49M
--4.64M
--8.19M
---20.40M
Financing cash flow
Cash flow from continuous financing activities
19.65%554.00K
10.00%22.00K
-46.17%24.38M
111.21%471.00K
29.69%463.00K
-45.95%20.00K
2264400.00%45.29M
--223.00K
--357.00K
--37.00K
--2.00K
--0.00
Net cash flow from common stock issuance/repurchase
139.84%307.00K
--0.00
-46.93%23.94M
----
-14.67%128.00K
100.00%0.00
--45.12M
----
--150.00K
---2.00K
----
----
Net cash flow from preferred stock issuance/repurchase
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
--0.00
Proceeds from stock option exercised by employees
-26.27%247.00K
-76.84%22.00K
53.45%511.00K
215.70%704.00K
-24.38%335.00K
-44.77%95.00K
16550.00%333.00K
--223.00K
--443.00K
--172.00K
--2.00K
----
Net cash flow from other financing activities
--0.00
100.00%0.00
53.46%-74.00K
---233.00K
100.00%0.00
43.61%-75.00K
---159.00K
----
---236.00K
---133.00K
--0.00
--0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
19.65%554.00K
10.00%22.00K
-46.17%24.38M
111.21%471.00K
29.69%463.00K
-45.95%20.00K
2264400.00%45.29M
--223.00K
--357.00K
--37.00K
--2.00K
--0.00
Net cash flow
Beginning cash balance
----
-48.98%31.07M
-65.67%9.12M
4.88%23.49M
43.54%32.18M
121.81%60.90M
-5.57%26.57M
-58.67%22.40M
--22.42M
--27.46M
--28.14M
--54.20M
Current period cash flow changes
130.34%2.64M
100.16%46.00K
-36.07%21.95M
-444.25%-14.37M
-39395.45%-8.69M
-470.09%-28.72M
5148.53%34.33M
116.02%4.17M
---22.00K
---5.04M
---680.00K
---26.06M
Ending cash balance
43.68%33.75M
-3.31%31.11M
-48.98%31.07M
-65.67%9.12M
4.88%23.49M
43.54%32.18M
121.81%60.90M
-5.57%26.57M
--22.40M
--22.42M
--27.46M
--28.14M
Free cash flow
----
-2.56%-16.04M
-36.47%-20.43M
-106.93%-23.67M
0.03%-14.86M
-60.39%-15.64M
-66.26%-14.97M
-101.09%-11.44M
---14.87M
---9.75M
---9.01M
---5.69M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
